New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - citric acid monohydrate 1.3 mg/ml; ipecacuanha liquid extract 0.002 ml/ml; promethazine hydrochloride 1.12 mg/ml; sulfogaiacol hemihydrate 9 mg/ml - linctus - active: citric acid monohydrate 1.3 mg/ml ipecacuanha liquid extract 0.002 ml/ml promethazine hydrochloride 1.12 mg/ml sulfogaiacol hemihydrate 9 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - pholcodine 1 mg/ml - linctus - 5mg/5ml, 10mg/5ml - active: pholcodine 1 mg/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - docetaxel -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - teriflunomide -

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - codeine phosphate hemihydrate 9.6mg; paracetamol 500mg;   - tablet - 9.6mg/500mg - active: codeine phosphate hemihydrate 9.6mg paracetamol 500mg   - for patients over the age of 12 for the symptomatic relief of acute moderate to severe pain including headache, toothache, backache or pain associated with trauma or surgery. the calmative properties may be especially useful in the treatment of tension headache, migraine and period pain and the antipyretic properties may be useful in controlling fever. mersyndol is a suitable alternative for those individuals who cannot tolerate aspirin.

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - bisacodyl 5mg - suppository - 5 mg - active: bisacodyl 5mg excipient: hard fat

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - pipotiazine palmitate 50 mg/ml;   - solution for injection - 50 mg/ml - active: pipotiazine palmitate 50 mg/ml   excipient: nitrogen sesame oil - piportil depot is a long-acting phenothiazine neuroleptic indicated for the maintenance treatment of schizophrenia and paranoid psychoses, and prevention of relapse, especially where compliance with oral medication is a problem.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - risedronate sodium; calcium carbonate; colecalciferol; cholecalciferol -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - pertussis fimbriae 2 + 3; pertussis filamentous haemagglutinin; tetanus toxoid; diphtheria toxoid; pertactin; pertussis toxoid -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - poliovirus -